Skip to main content
. 2019 Sep 2;2019(9):CD011462. doi: 10.1002/14651858.CD011462.pub2

9. Modified LENT‐SOMA radiation therapy late effects.

Toxicity Grade I Grade II Grade III Grade IV
Genitourinary Nocturia twice baseline or non‐narcotic medication (e.g. α‐blocker) once per day increase over baseline
Microscopic hematuria
Light mucosal atrophy and minor telangiectasia
Dysuria not requiring medication
Incontinence or dribbling not requiring sanitary pad (over baseline)
Frequency ≤ every hour requiring α‐blocker > once per day
Nocturia > twice baseline
Generalized telangiectasias
Macroscopic hematuria requiring ≤ 2 cauterization
Dysuria requiring medication (non‐narcotic > once per day or narcotic for pain ≥ 1 per day over baseline)
≤ 2 dilations Foley or self‐catheterization for ≤ 2 weeks' incontinence requiring ≤ 2 pads (over baseline)
Frequency > 1 every hour or dysuria requiring narcotic > once per day
Nocturia > 1 per hour
Reduction in bladder capacity (150 cm3) ≥ 1 blood transfusions or > 2 cauterizations for bleeding
Narcotic use > once per day
Hyperbaric oxygen
Foley or self‐catheterization > 2 weeks
TURP or > 2 dilations
Incontinence requiring > 2 pads (over baseline)
Gross hematuria requiring > 1 blooded transfusion
Severe hemorrhagic cystitis or ulceration requiring urinary diversion with or without cystectomy

LENT‐SOMA: Late Effects Normal Tissue Task Force‐Subjective, Objective, Management, Analytic; TURP: transurethral resection of the prostate.